Infections are the most frequent complications of antineoplastic chemotherapy, and are facilitated by mucositis and neutropenia, both common side-effects of antineoplastic agents. The present paper addresses the principles of the use of hematopoietic growth factors in this indication, considering their primary and secondary use and discussing other possible indication.
|Translated title of the contribution||Indications of hematopoietic growth factors in the management of infectious complications of chemotherapy|
|Number of pages||5|
|Journal||Inflamacion y Regulacion del Crecimiento Celular|
|State||Published - Jan 1 1996|
- hematopoietic growth factors
ASJC Scopus subject areas